Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Metab ; 11(2): 161-71, 2010 Feb 03.
Article in English | MEDLINE | ID: mdl-20142103

ABSTRACT

Parathyroid hormone (PTH) suppresses Dickkopf 1 (Dkk1) expression in osteoblasts. To determine whether this suppression is essential for PTH-mediated Wnt signaling and bone formation, we examined mice that overexpress Dkk1 in osteoblasts (Dkk1 mice). Dkk1 mice were osteopenic due to abnormal osteoblast and osteoclast activity. When fed a low-calcium diet, and in two other models of hyperparathyroidism, these mice failed to develop the peritrabecular stromal cell response ("osteitis fibrosis") and new bone formation seen in wild-type mice. Despite these effects of Dkk1 overexpression, PTH still activated Wnt signaling in Dkk1 mice and in osteoblastic cells cultured from these mice. In cultured MC3T3E1 preosteoblastic cells, PTH dramatically suppressed Dkk1 expression, induced PKA-mediated phosphorylation of beta-catenin, and significantly enhanced Lef1 expression. Our findings indicate that the full actions of PTH require intact Wnt signaling but that PTH can activate the Wnt pathway despite overexpression of Dkk1.


Subject(s)
Intercellular Signaling Peptides and Proteins/metabolism , Osteogenesis , Parathyroid Hormone/metabolism , Stromal Cells/metabolism , Wnt Proteins/metabolism , Animals , Bone Marrow Cells/metabolism , Cell Line , Cell Proliferation , Cells, Cultured , Gene Expression Regulation , Humans , Intercellular Signaling Peptides and Proteins/genetics , Mice , Mice, Inbred C57BL , Osteoblasts/metabolism , Osteoclasts/metabolism , RNA, Messenger/genetics , Signal Transduction
2.
Bone ; 40(4): 1103-9, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17258520

ABSTRACT

Serum PINP has emerged as a reliable marker of bone turnover in humans and is routinely used to monitor bone formation. However, the effects of PTH (1-34) on bone turnover have not been evaluated following short-term treatment. We present data demonstrating that PINP is an early serum biomarker in the rat for assessing bone anabolic activity in response to treatment with PTH (1-38). Rat serum PINP levels were found to increase following as few as 6 days of treatment with PTH (1-38) and these increases paralleled expression of genes associated with bone formation, as well as, later increases in BMD. Additionally, PINP levels were unaffected by treatment with an antiresorptive bisphosphonate. PINP may be used to detect PTH-induced early bone formation in the rat and may be more generally applicable for preclinical testing of potential bone anabolic drugs.


Subject(s)
Bone Remodeling/physiology , Osteogenesis/physiology , Peptide Fragments/blood , Procollagen/blood , Animals , Biomarkers/blood , Bone Remodeling/drug effects , Bone Remodeling/genetics , CCN Intercellular Signaling Proteins , Carboxypeptidases/genetics , Collagen/genetics , Collagen Type I , Female , Gene Expression/drug effects , Humans , Oncogene Proteins/genetics , Osteocalcin/genetics , Osteogenesis/drug effects , Osteogenesis/genetics , Ovariectomy , Parathyroid Hormone/pharmacology , Peptide Fragments/pharmacology , Proto-Oncogene Proteins , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Recombinant Proteins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...